CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing Macrophage-Drug Conjugates (MDCs) to enhance the delivery of anti-cancer drugs directly to solid tumors, particularly in hypoxic regions. By utilizing macrophages as carriers, the project aims to improve treatment efficacy and facilitate commercialization of this innovative technology…
New therapeutic approaches have led to significant improvements in cancer treatment, but none have been able to overcome the limited efficacy of solid tumor treatment due to poor tumor delivery and the presence of hypoxic tumor cells.
Macrophages represent a promising vesicle to deliver cancer therapeutics to solid tumors as they are continuously recruited into the tumor mass, even the most hypoxic regions.
Our pioneering research demonstrated that macrophages are able to take up ferritins loade…
SGGW WARSAW UNIVERSITY OF LIFE SCIENCES
SZKOLA GLOWNA GOSPODARSTWA WIEJSKIEGO
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
